Retinoic acid increases the effect of bone morphogenetic protein type 2 on osteogenic differentiation of human adipose-derived stem cells Bone morphogenetic protein type 2 (BMP-2) and retinoic acid (RA) are osteoinductive factors that stimulate endogenous mechanisms of bone repair which can be applied on management of osseous defects in oral and activity was determined using the r-nitrophenol method. Extracellular matrix mineralization was evaluated using von Kossa staining and calcium quantification. Expression of osteonectin and osteocalcin mRNA were determined using qPCR. Smad1, Smad4, phosphorylated Smad1/5/8, BMP-4, and BMP-7 proteins expressions were analyzed using western blotting.
Introduction
The repair of extensive bone defects remains a challenge in Dentistry. Given the drawbacks of the available bone graft materials, scientists have been searching for new substances and combinations to be used as osteoinductive factors. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor (TGF) super-family and were initially identified by their ability to induce ectopic bone formation. 1 BMP type 2 (BMP-2) is one of the most studied osteoinductive factors that has been used for osteogenic differentiation of mesenchymal stem cells for bone repair in oral and maxillofacial surgeries. 2, 3 However, in addition to its high cost, BMP-2 use has been related with adverse effects such as substantial swelling, erythema, and pain. [4] [5] [6] Retinoic acid (RA) is a vitamin A-derived compound that is critical in embryonic development and maintenance of vital organs in adults. 7 Some in vitro studies have shown that RA is involved in up-regulation of osteogenic genes, increasing osteogenic differentiation of different cell types including osteosarcoma-derived cells, osteoblasts, preadipocytes, and mesenchymal stem cells. [8] [9] [10] [11] RA has also been related to the enhancement of BMP-
effects by increasing alkaline phosphatase (ALP)
activity, RunX2 transcription factor, and osteopontin mRNA expression during chondrocytic and osteoblastic differentiation of mouse cells. 12, 13 Moreover, Cowan, et al. 14 (2005) demonstrated that BMP-2 combined with RA accelerates in vivo bone formation. However, the outcomes of RA, alone or combined with BMP-2, on osteogenic differentiation are controversial, since
Wang, et al. 15 (2008) demonstrated that RA inhibits osteogenic differentiation of rat bone marrow stromal cells, Ogston, et al. 16 (2002) and Takahashi, et al. 17 (2008) showed a reduction on ALP activity by RA, and Hoffman, et al. 18 (2006) USA) were used as positive controls in ALP activity, matrix mineralization, and western blotting assays.
MC3T3-E1 cells were cultured according to the supplier's recommendations in αMEM modified with 5 µM ascorbate and 10 mM β-glycerophosphate.
I m m u n o p h e n o t y p i n g a n d m u l t i l i n e a g e differentiation of ASCs were performed to confirm the mesenchymal stem cells characteristics, as previously described. 19 Determination of alkaline phosphatase activity 
Results
The confirmation that the ASCs used in this report were mesenchymal stem cells was previously At day 7, the BMP-2 treated group expressed the highest BMP-7 amount, followed by BMP-2+RA, RA, OM, and MC3T3-E1 groups (ρ<0.0001). The highest BMP-7 expression was exhibited by MC3T3-E1, followed by BMP-2, RA, OM, and BMP-2+RA at day 14 (ρ<0.0001). At day 21, BMP-2 demonstrated the highest BMP-7 expression, followed by BMP-2+RA, RA, MC3T3-E1, and OM groups (ρ<0.0001). Finally, RA showed the highest expression at day 28, followed by OM, BMP-2, MC3T3-E1, and BMP-2+RA (ρ<0.0001).
Signaling pathways analysis
IPA ® analysis indicated that the major changes in BMP signaling pathway occurred at days 14 and 21 (Table 1) 
BMP signaling pathway -Day 7 BMP signaling pathway -Day 21
Observation Z-score ρ value Observation Z-score ρ value 1-Relation between the different cell treatments and the BMP signaling pathway indicated by IPA ® software at days 7, 14, 21, and 28. ASCs were treated according to the groups: OM (osteogenic medium); BMP-2 (OM and BMP-2); RA (OM and retinoic acid, RA); BMP-2+RA (OM, BMP-2, and RA). MC3T3-E1 was used as positive control. r<0.05 represents statistically significant difference. Positive z-score indicates up-regulation (highlighted in orange) and negative z-score implies down-regulation (highlighted in blue) of the signaling pathway evidenced by the IPA ® software (v=versus) We also observed that BMP-2+RA up-regulated the BMP signaling pathway when compared to BMP- 
